Literature DB >> 30445524

Corrigendum: Estimation of clinical trial success rates and related parameters.

Chi Heem Wong1,2, Kien Wei Siah1,2, Andrew W Lo1,2,3.   

Abstract

Year:  2019        PMID: 30445524      PMCID: PMC6409416          DOI: 10.1093/biostatistics/kxy072

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


× No keyword cloud information.
Biostatistics (2019) 20, 2, pp. 273–286 doi:10.1093/biostatistics/kxx069 In the original article, there were errors in Tables 1 and 2, specifically Phase 2 to 3 and Phase 3 to APP in Table 1, and Phase 2 to 3 columns in Table 2. Due to a formatting issue in Excel, incorrect numbers were reported originally. There was a mis-match in the data between the pdf and the HTML article which has now been rectified. The tables have now been corrected. The author and Publisher apologizes for these errors. Click here for additional data file.
  10 in total

1.  Positron Emission Tomography Imaging of [11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A.

Authors:  Sarah Billington; Steven Shoner; Scott Lee; Kindra Clark-Snustad; Matthew Pennington; David Lewis; Mark Muzi; Shirley Rene; Jean Lee; Tot Bui Nguyen; Vineet Kumar; Kazuya Ishida; Laigao Chen; Xiaoyan Chu; Yurong Lai; Laurent Salphati; Cornelis E C A Hop; Guangqing Xiao; Mingxiang Liao; Jashvant D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

Review 2.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

3.  Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression.

Authors:  Cuiqin Fan; Ye Li; Tian Lan; Wenjing Wang; Yifei Long; Shu Yan Yu
Journal:  Mol Ther       Date:  2021-11-10       Impact factor: 11.454

Review 4.  Assessing Multiple Factors Affecting Minority Participation in Clinical Trials: Development of the Clinical Trials Participation Barriers Survey.

Authors:  Karen Allison; Deepkumar Patel; Ramandeep Kaur
Journal:  Cureus       Date:  2022-04-23

5.  High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics.

Authors:  Chun-Wei Chi; Yeh-Hsing Lao; A H Rezwanuddin Ahmed; Elizabeth C Benoy; Chenghai Li; Zeynep Dereli-Korkut; Bingmei M Fu; Kam W Leong; Sihong Wang
Journal:  Adv Healthc Mater       Date:  2020-09-23       Impact factor: 9.933

Review 6.  Multicellular 3D Models to Study Tumour-Stroma Interactions.

Authors:  Elisabetta Colombo; Maria Grazia Cattaneo
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 7.  In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview.

Authors:  Zhiqin Li; Sigrid A Langhans
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

Review 8.  Gene editing monkeys: Retrospect and outlook.

Authors:  Weizheng Liang; Junli He; Chenyu Mao; Chengwei Yu; Qingxue Meng; Jun Xue; Xueliang Wu; Shanliang Li; Yukai Wang; Hongyang Yi
Journal:  Front Cell Dev Biol       Date:  2022-09-08

9.  The use of external control data for predictions and futility interim analyses in clinical trials.

Authors:  Steffen Ventz; Leah Comment; Bill Louv; Rifaquat Rahman; Patrick Y Wen; Brian M Alexander; Lorenzo Trippa
Journal:  Neuro Oncol       Date:  2022-02-01       Impact factor: 13.029

10.  Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer.

Authors:  Clara Louise Hedegaard; Carlos Redondo-Gómez; Bee Yi Tan; Kee Woei Ng; Daniela Loessner; Alvaro Mata
Journal:  Sci Adv       Date:  2020-10-02       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.